HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Construction and characterization of porcine single-chain fragment variable antibodies that neutralize transmissible gastroenteritis virus in vitro.

Abstract
Transmissible gastroenteritis virus (TGEV) infection causes severe diarrhea in piglets and imposes a significant economic burden on pig farms. Single-chain fragment variable (scFv) antibodies effectively inhibit virus infection and could be a potential therapeutic reagent for preventing disease. In this study, a recombinant scFv antibody phage display library was constructed from peripheral blood lymphocytes of piglets infected with TGEV. The library was screened with four rounds of biopanning using purified TGEV antigen, and scFv antibodies that bound to TGEV were obtained. The scFv gene was subcloned into the pET-28a(+), and the constituted plasmid was introduced into Escherichia coli BL21 (DE3) for protein expression. All three scFv clones identified had neutralizing activity against TGEV. An immunofluorescence assay and western blot analysis demonstrated that two scFv antibodies reacted with the spike protein of TGEV. These results indicate that scFv antibodies provide protection against viral infection in vitro and may be a therapeutic candidate for both prevention and treatment of TGEV infection in swine.
AuthorsFanqing Zhang, Yuxue Chen, Liang Yang, Jianguo Zhu
JournalArchives of virology (Arch Virol) Vol. 164 Issue 4 Pg. 983-994 (Apr 2019) ISSN: 1432-8798 [Electronic] Austria
PMID30729994 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Viral
  • Single-Chain Antibodies
Topics
  • Animals
  • Antibodies, Viral (genetics, immunology)
  • Gastroenteritis, Transmissible, of Swine (immunology, virology)
  • Neutralization Tests
  • Single-Chain Antibodies (genetics, immunology)
  • Swine
  • Transmissible gastroenteritis virus (genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: